This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2011 Remove Analytical Chemistry Remove Licensing Related Topics
Clinical Development Licensing RNA Clinical Research Small Molecule DNA Pharmaceuticals FDA Approval Trials Treatment More Related Topics >
article thumbnail

International Women’s Day: Female life science leaders

Drug Discovery World

MARCH 7, 2023

Linda Powers, CEO, Northwest Biotherapeutics Powers has served as the Chairman of NW Bio since 2007, and as CEO since 2011. She has over 15 years’ experience in corporate finance and restructurings, mergers and acquisitions, joint ventures and intellectual property licensing.

International 246
International Science Pharmaceuticals DNA 246
article thumbnail

BioSpace Movers & Shakers, Nov. 6

The Pharma Data

NOVEMBER 5, 2020

Prior to this, he held a position as a director of Analytical Chemistry in Drug Discovery at GlaxoSmithKline. Most recently, Holland served as Global Head of licensing at Lonza AG. Denner has been with Sarissa since 2011. From 2006 to 2011, Denner served as a senior managing director at Icahn Capital L.P.

Analytical Chemistry 40
Analytical Chemistry Pharmaceuticals Small Molecule Therapies 40
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 42,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024